Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American ...
Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent ...
Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...